Prenatal effects of transplacental exposure to ifosfamide in rats

References

• Ajithkumar T, Parkinson C, Shamshad F, Murray P (2007)Ifosfamide encephalopathy. Clin. Oncol. (R. Coll. Radiol.) 19: 108–114.
   PubMed Web of Science ®Google Scholar
• Ames B, Lewis L, Chaffee S, Kim J, Morse R (2010)Ifosfamide induced encephalopathy and movement disorder. Ped. Blood Cancer 54: 624–626.
   PubMed Web of Science ®Google Scholar
• Battaglia F, Meschia G (1986)Fetal and placental growth. In: Battaglia FC, Meschia G, Eds. An Introduction to Fetal Physiology, 1st ed., Academic Press, Orlando, FL. pp. 1–27.
   Google Scholar
• Cerny T, Küpfer A (1992)The enigma of ifosfamide encephalopathy. Ann. Oncol. 3: 679–681.
   PubMed Web of Science ®Google Scholar
• Chen N, Aleksa K, Woodland C, Rieder M, Koren G (2008)N-acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br. J. Pharmacol 153: 1364–1372.
   PubMed Web of Science ®Google Scholar
• D’Incalci M, Sessa C, Colombo N, de Palo G, Semprini A, Pardi G (1982)Transplacental passage of cyclophosphamide. Cancer Treat. Rep. 66: 1681–1682.
   PubMedGoogle Scholar
• Diwan BA, Anderson LM, Ward JM, Henneman JR, Rice JM (1995)Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital. Toxicol. Appl. Pharmacol. 132: 115–121.
   PubMed Web of Science ®Google Scholar
• El-Sisi A, El-Syaad M, El-Desoky K, Moussa E (2013)Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide induced nephrotoxicity. Toxicol. Ind. Health 12: 1–11.
   Google Scholar
• Ema M, Miyawaki E (2002)Suppression of uterine decidualization correlated with reduction in serum progesterone levels as a cause of preimplantation embryonic loss induced by diphenyltin in rats. Reprod. Toxicol. 16: 309–317.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Hayashi S, Usuda K, Abe M, Hagio S, Ogawa I (2011)Toxicological pathology in the rat placenta. J. Toxicol. Pathol. 24: 95–111.
   PubMed Web of Science ®Google Scholar
• Ginis Z, Ozturk G, Albayrak A, Kurt SN, Albayrak M, Fadillioglu E (2016)Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats. Toxicol. Ind. Health 32: 337–343.
   PubMed Web of Science ®Google Scholar
• Goodman DR, James RC, Harbison RD (1982)Placental toxicology. Food Chem. Tox. 20: 123–128.
   PubMed Web of Science ®Google Scholar
• Harris HR (1900)On the rapid conversion of haematoxylin into haematein in staining reactions. J. Appl. Microsc. 3: 777–780.
   Google Scholar
• Hilton J (1984)Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide incyclophosphamide-sensitive and -resistant L1210 cells. Biochem. Pharmacol. 33: 1867–1872.
   PubMed Web of Science ®Google Scholar
• Kaina B (2004)Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go. Cytogenet. Genom. Res. 104: 77–86.
   PubMed Web of Science ®Google Scholar
• Katayama K, Ueno M, Takai H, Ejiri N, Uetsuka K, Nakayama H, Doi K (2002)Ethylnitrosourea induced apoptosis and growth arrest in the trophoblastic cells of rat placenta. Biol. Reprod. 67: 431–435.
   PubMed Web of Science ®Google Scholar
• Kerbusch T, de Kraker J, Keizer HJ, Putten JWG, Groen HJM, Jansen RLH, Schellens JHM, Beijnen JH (2001)Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Clin. Pharmacokinet. 40: 41–62.
   PubMed Web of Science ®Google Scholar
• Kim JC, Shin JY, Yang YS, Shin DH, Moon CJ, Kim SH (2007)Evaluation of developmental toxicity of amitraz in Sprague-Dawley rats. Arch. Environ. Contam. Toxicol. 52 : 137–144.
   PubMed Web of Science ®Google Scholar
• Klastersky J (2003)Side effects of ifosfamide. Oncology 65 (Suppl. 2): 7–10.
   PubMed Web of Science ®Google Scholar
• Kopf-Maier P, Erkenswick P, Merker H (1985)Lack of severe malformations versus occurrence of marked embryotoxic effects after treatment of pregnant mice with cis-platinum. Toxicology 34: 321–331.
   PubMed Web of Science ®Google Scholar
• Loebstein R, Koren G (1998)Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics 101: E8–E12.
   PubMed Web of Science ®Google Scholar
• Matthews MK, Kenyon R (1984)Four- versus five-day estrous cycles in rats: vaginal cycling and pregnancy. Physiol. Behav. 33: 65–67.
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Narama I (1982)Reproductive studies of ifosfamide (Z 4942). Organogenesis administration in rabbits. Kiso Rinsho 16: 542–552.
   Google Scholar
• Nagaoka T, Takatsuka K, Narama I (1982)Reproductive studies of ifosfamide (Z 4942). Preconceptional and early pregnancy administration in rats. Kiso Rinsho 16: 508–516.
   Google Scholar
• Nissim I, Horyn O, Daikhin Y, Nissim I, Luhovyy B, Phillips P, Yudkoff M (2006)Ifosfamide-Induced nephrotoxicity: mechanism and prevention. Cancer Res. 66: 7824–7831.
   PubMed Web of Science ®Google Scholar
• Quinto I, De Marinis E, De Dominicis G, Della Morte R, Staiano N (1988)Induction of sperm abnormalities in mice by ifosfamide and trofosfamide. Muta. Res. 201: 113–116.
   PubMed Web of Science ®Google Scholar
• Richards A, Marshall H, Mc Quary A (2011)Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity. J. Oncol. Pharm. Pract. 17: 372–380.
   PubMedGoogle Scholar
• Rossi R, Pleyer J, Schafers P, Kuhn N, Kleta R, Deufel T (1999)Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med. Pediat. Oncol. 32: 177–182.
   PubMedGoogle Scholar
• Sehirli O, Sakarcan A, Velioglu-Ogunc A, Cetinel S, Nursal G, Yegen BC, Şener G (2007)Resveratrol improves ifosfamide-induced Fanconi syndrome in rats. Toxicol. Appl. Pharmacol. 222: 33–41.
   PubMed Web of Science ®Google Scholar
• Sener G, Sehirli O, Yegen B, Cetinel S, Gedik N, Sakarcan A (2004)Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats. J. Pineal Res. 37: 17–25.
   PubMed Web of Science ®Google Scholar
• Sood C, O’Brien P (1994)Chloroacetaldehyde induced hepatocyte cytotoxicity: mechanisms for cytoprotection. Biochem. Pharmacol. 48: 1025–1032.
   PubMed Web of Science ®Google Scholar
• Struck RF, Davis RL, Berardini MD, Loechler EL (2000)DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide. Cancer Chemother. Pharmacol. 45: 59–62.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Coppola D, Matsushita N, Cualing H, Sun M, Sato Y, Liang C, Jung J, Cheng J, Pledger W, Wang H (2007)Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 9: 1142–1151.
   PubMed Web of Science ®Google Scholar
• Takimoto CH, Calvo E (2008)Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, Eds., Cancer Management: a Multidisciplinary Approach. 11th ed. UBM Medica, London, UK. pp. 42–58.
   Google Scholar
• Torchinsky A, Lishanski L, Wolstein O, Shepshelovich J, Orenstein H, Savion S, Zaslavsky Z, Carp H, Brill A, Dikstein R, Toder V, Fein A (2002)NF-κB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide. BMC Dev. Biol. 2: 1–11.
   PubMedGoogle Scholar
• Van Calsteren K (2010)Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. Facts Views Vis ObGyn. 2: 278–286.
   PubMedGoogle Scholar
• Weigt S, Huebler N, Strecker R, Braunbeck T, Broschard T (2011)Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology 281: 25–36.
   PubMed Web of Science ®Google Scholar
• WHO (2015)19th WHO Model List of Essential Medicines (April 2015) (PDF). WHO. April 2015. Retrieved May 10, 2015.
   Google Scholar
• Yazawa Y, Takagi T, Asakura S, Suzuki K, Kano Y (1999)Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines. J. Orthop. Sci. 4: 231–237.
   PubMedGoogle Scholar
• Yeh J, Kim BS, Peresie J (2011)Reproductive toxic effects of cisplatin and its modulation by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats. Reprod. Biol. Insights 5: 17–27.
   Google Scholar
• Zhang J, Tian Q, Chan SY, Duan W, Zhou S (2005)Insights into oxazaphosphorine resistance and possible approaches to its circumvention. Drug Resist. Update 8: 271–297.
   PubMed Web of Science ®Google Scholar